Investigators developed a genomic score to assess potential survival benefits in patients with neuroendocrine neoplasms treated with immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results